Sutro Biopharma (STRO) Net Margin (2017 - 2025)
Sutro Biopharma (STRO) reported Net Margin of 708.42% for Q4 2025, down 21924.0% on a YoY basis from N/an in Q4 2024, and down 20.77% sequentially from 586.58% in Q3 2025.
Sutro Biopharma (STRO) Net Margin (2017 - 2025) Analysis & Trends
Sutro Biopharma (STRO) has 9 years of Net Margin data on file, last reported at 708.42% in Q4 2025.
- For the quarter ending Q4 2025, Net Margin fell 21924.0% year-over-year to 708.42%; the trailing twelve-month figure through Dec 2025 stood at 187.54% (up 17907.0% YoY), and the FY2025 full-year result was 186.45%, up 18017.0% from the prior year.
- Net Margin retreated to 708.42% in Q4 2025, from 586.58% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 27.31% in Q4 2023 to a low of 708.42% in Q4 2025.
- A 5-year average of 326.87% and a median of 366.41% in 2021 frame the typical range for Net Margin.
- Across the five-year window, Net Margin plunged 52904 bps in 2022 and surged 42807 bps in 2023, its largest moves.
- Tracing STRO's Net Margin over 5 years: stood at 357.85% in 2021, then fell by 12 bps to 400.76% in 2022, then surged by 107 bps to 27.31% in 2023, then sank by 1891 bps to 489.18% in 2024, then sank by 45 bps to 708.42% in 2025.
- Business Quant data shows STRO's Net Margin at 708.42% in Q4 2025, 586.58% in Q3 2025, and 18.04% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - | -708.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -708.42% |
| Sep 30, 2025 | -586.58% |
| Jun 30, 2025 | -18.04% |
| Mar 31, 2025 | -388.67% |
| Dec 31, 2024 | -489.18% |
| Sep 30, 2024 | -572.62% |
| Jun 30, 2024 | -186.80% |
| Mar 31, 2024 | -447.52% |
| Dec 31, 2023 | 27.31% |
| Sep 30, 2023 | -291.21% |
| Jun 30, 2023 | -370.00% |
| Mar 31, 2023 | -394.90% |
| Dec 31, 2022 | -400.76% |
| Sep 30, 2022 | -77.50% |
| Jun 30, 2022 | -92.58% |
| Mar 31, 2022 | -663.22% |
| Dec 31, 2021 | -357.85% |
| Sep 30, 2021 | -362.83% |
| Jun 30, 2021 | -21.93% |
| Mar 31, 2021 | -134.17% |